CN1742957A - Sangju effervescent tablet for treating common cold - Google Patents
Sangju effervescent tablet for treating common cold Download PDFInfo
- Publication number
- CN1742957A CN1742957A CN 200510019524 CN200510019524A CN1742957A CN 1742957 A CN1742957 A CN 1742957A CN 200510019524 CN200510019524 CN 200510019524 CN 200510019524 A CN200510019524 A CN 200510019524A CN 1742957 A CN1742957 A CN 1742957A
- Authority
- CN
- China
- Prior art keywords
- effervescent tablet
- sangju
- sang
- common cold
- treating common
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007938 effervescent tablet Substances 0.000 title claims abstract description 108
- 201000009240 nasopharyngitis Diseases 0.000 title claims abstract description 44
- 239000003795 chemical substances by application Substances 0.000 claims description 63
- 239000000284 extract Substances 0.000 claims description 44
- 239000000203 mixture Substances 0.000 claims description 30
- 239000011230 binding agent Substances 0.000 claims description 17
- 239000000314 lubricant Substances 0.000 claims description 16
- 125000003118 aryl group Chemical group 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 9
- 241000628997 Flos Species 0.000 claims description 8
- 239000002671 adjuvant Substances 0.000 claims description 7
- 239000000470 constituent Substances 0.000 claims description 7
- 239000003814 drug Substances 0.000 abstract description 46
- 238000002360 preparation method Methods 0.000 abstract description 36
- 239000000463 material Substances 0.000 abstract description 7
- 206010011224 Cough Diseases 0.000 abstract description 3
- 241000555682 Forsythia x intermedia Species 0.000 abstract description 2
- 206010019233 Headaches Diseases 0.000 abstract description 2
- 208000005946 Xerostomia Diseases 0.000 abstract description 2
- 231100000869 headache Toxicity 0.000 abstract description 2
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 244000246386 Mentha pulegium Species 0.000 abstract 1
- 235000016257 Mentha pulegium Nutrition 0.000 abstract 1
- 235000004357 Mentha x piperita Nutrition 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 206010068319 Oropharyngeal pain Diseases 0.000 abstract 1
- 201000007100 Pharyngitis Diseases 0.000 abstract 1
- 244000018633 Prunus armeniaca Species 0.000 abstract 1
- 235000009827 Prunus armeniaca Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 235000001050 hortel pimenta Nutrition 0.000 abstract 1
- 238000000034 method Methods 0.000 description 38
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 37
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 30
- 239000008187 granular material Substances 0.000 description 29
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 28
- 239000002552 dosage form Substances 0.000 description 27
- 239000000686 essence Substances 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 20
- 239000000843 powder Substances 0.000 description 19
- 239000007787 solid Substances 0.000 description 19
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 16
- 238000004321 preservation Methods 0.000 description 16
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 14
- 229930003268 Vitamin C Natural products 0.000 description 14
- 239000011718 vitamin C Substances 0.000 description 14
- 235000019154 vitamin C Nutrition 0.000 description 14
- 235000015165 citric acid Nutrition 0.000 description 13
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 12
- 239000001527 calcium lactate Substances 0.000 description 12
- 235000011086 calcium lactate Nutrition 0.000 description 12
- 229960002401 calcium lactate Drugs 0.000 description 12
- 230000036541 health Effects 0.000 description 12
- 229960004106 citric acid Drugs 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 10
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- 229910000029 sodium carbonate Inorganic materials 0.000 description 10
- 235000017550 sodium carbonate Nutrition 0.000 description 10
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 9
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 9
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 9
- 239000008108 microcrystalline cellulose Substances 0.000 description 9
- 229940016286 microcrystalline cellulose Drugs 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- 239000003826 tablet Substances 0.000 description 9
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 8
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 8
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 8
- 235000017557 sodium bicarbonate Nutrition 0.000 description 8
- 239000008118 PEG 6000 Substances 0.000 description 7
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 7
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 6
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 6
- 235000010357 aspartame Nutrition 0.000 description 6
- 239000011975 tartaric acid Substances 0.000 description 6
- 235000002906 tartaric acid Nutrition 0.000 description 6
- 108010011485 Aspartame Proteins 0.000 description 5
- 235000010358 acesulfame potassium Nutrition 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000000605 aspartame Substances 0.000 description 5
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 5
- 229960003438 aspartame Drugs 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000007689 inspection Methods 0.000 description 5
- 235000019359 magnesium stearate Nutrition 0.000 description 5
- 235000011090 malic acid Nutrition 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 235000011181 potassium carbonates Nutrition 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229960004998 acesulfame potassium Drugs 0.000 description 4
- 239000000619 acesulfame-K Substances 0.000 description 4
- 229940109275 cyclamate Drugs 0.000 description 4
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 4
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229960005069 calcium Drugs 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 239000011812 mixed powder Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 244000144725 Amygdalus communis Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241000234295 Musa Species 0.000 description 2
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 2
- 235000003893 Prunus dulcis var amara Nutrition 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 description 2
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 229950005770 hyprolose Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 238000005453 pelletization Methods 0.000 description 2
- 239000011736 potassium bicarbonate Substances 0.000 description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 235000014435 Mentha Nutrition 0.000 description 1
- 241001072983 Mentha Species 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002313 adhesive film Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- -1 and sour Substances 0.000 description 1
- 229960004543 anhydrous citric acid Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- SMHNUIFHMAGAFL-UHFFFAOYSA-N calcium;2-hydroxypropanoic acid Chemical compound [Ca].CC(O)C(O)=O SMHNUIFHMAGAFL-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229960002598 fumaric acid Drugs 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000008921 jie er yin Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- HWPKGOGLCKPRLZ-UHFFFAOYSA-M monosodium citrate Chemical compound [Na+].OC(=O)CC(O)(C([O-])=O)CC(O)=O HWPKGOGLCKPRLZ-UHFFFAOYSA-M 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229940001593 sodium carbonate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese medicine Sangju Ganmao effervescent tablet for curing wind-heat common cold, headache, cough, mouth dryness and sore throat. Specially, it is a ring-shaped effervescent tablet made up by using 8 Chinese medicinal materials of mulberry leaf, chrysanthemum flower, bitter apricot kernel, forsythia fruit, peppermint and others. Said invention also provides its preparation method.
Description
Technical field
The present invention relates to the technical field of Chinese patent medicine effervescent tablet, relate in particular to Sangju effervescent tablet for treating common cold.
Background technology
At present, the domestic main effervescent tablet of China is health product, as vitamin C, the effervescent tablet of replenishing the calcium, also has plenty of the effervescent tablet of gynecological external use medicine, as JIEERYIN PAOTENGPIAN, and metronidazole vagina effervescent tablet etc., but the oral Chinese medicine effervescent formulation is less.And Sang Ju Yin flu prescription is made the effervescent tablet of oral pure Chinese medicinal preparation, rarely found report.In addition, ring segment early has application in food industry, but less in the field of medicaments application, particularly in the effervescent tablet preparation field, and rarely found report.
The Chinese medicine effervescent tablet is a kind of new dosage form, have that drug release rate is fast, dosage is little, divided dose is accurate, take, advantage such as easy to carry, and the oral administration effervescing sheet is specially adapted to the patient of child, old people and the solid preparation of can not swallowing.
The effect of Sang Ju Yin flu class Chinese patent medicine is a wind and heat dispersing, the lung qi dispersing cough-relieving.Be used for anemopyretic cold from the beginning of, the headache, the cough, xerostomia, pharyngalgia.Former dosage form is a liquid, carries inconvenience.
The raw material of Chinese medicine of Sang Ju Yin flu mixture is made up of Folium Mori, Flos Chrysanthemi, Semen Armeniacae Amarum, Fructus Forsythiae, Herba Menthae, Radix Platycodonis, Rhizoma Phragmitis, Radix Glycyrrhizae.
Conventional Chinese medicine effervescent tablet adopts the form of conventional tablet, and disintegration rate is too slow, and the time that patient waits for is oversize, easily causes impatient emotion, influences Chinese medicine effervescent tablet commercial value.The administrative provisions of Chinese medicine effervescent tablet for example, the disintegration time of effervescent tablet is higher than 5 minutes, is judged to defective.This is because of slow excessively disintegration rate, inconvenient patient's treatment.
It is long partially that the health care products effervescent dosage form of Chinese medicine effervescent dosage form and other two big classes and Western medicine effervescent dosage form are compared on disintegration time, influenced the application of Chinese medicine effervescent dosage form.
Health product effervescent dosage form contains the material that easily is dissolved in water mostly, for example easily is dissolved in the small-molecule substance and the inorganic compound of water, and disintegrate is very fast; The common dose of Western medicine is little, and easily is dissolved in water, and Western medicine only accounts for below 3% of Western medicine effervescent formulation weight usually, and all the other all can adopt acid, alkali disintegrating agent, and sour, alkali disintegrating agent can be up to more than 90%, so the disintegrate of Western medicine effervescent chance water is also very fast; Health care products effervescent dosage form and Western medicine effervescent dosage form even are finished disintegrate usually in one minute in the several seconds, therefore do not have the technical problem of poor practicability on disintegration time.And Chinese medicine is when making the effervescent dosage form, usually water is carried with alcohol extraction and is obtained multiple blended macromolecular active substance, comprise multiple stickums such as pectin class, saccharide, polysaccharide, Chinese medicine effervescent dosage form is met the influence that the water disintegrate is subjected to stickum, disintegrate is slower, on the other hand for guaranteeing curative effect, the Chinese medicine effervescent dosage form dose of monolithic is bigger, this has also influenced disintegration rate, for guaranteeing disintegrate, have to increase the consumption of adjuvant, make some effervescent tablet will accomplish the 4-5g/ sheet, not only increased cost, also made troubles to producing, transport, carry, using.After the disintegration rate of Chinese medicine effervescent reached several minutes, compare advantage with Chinese medicine granules not outstanding, limited the application of Chinese medicine effervescent.
Summary of the invention
The purpose of this invention is to provide a kind of Sangju effervescent tablet for treating common cold,, satisfy needs of medical treatment better to overcome the deficiency of present dosage form.
The fast Sang Ju Yin of a kind of disintegration rate annular effervescent tablet of catching a cold particularly is provided.
Each constituent of Sangju effervescent tablet for treating common cold of the present invention comprises Sang Ju Yin flu extract, disintegrating agent and other adjuvant, and Sang Ju Yin flu extract is wherein made by the following weight Chinese medicinal raw materials: Folium Mori 160-240, Flos Chrysanthemi 40-120, Semen Armeniacae Amarum 120-200, Fructus Forsythiae 80-160, Herba Menthae 40-100, Radix Platycodonis 120-200, Rhizoma Phragmitis 120-200, Radix Glycyrrhizae 40-100.
Each constituent of Sangju effervescent tablet for treating common cold of the present invention comprises Sang Ju Yin flu extract, disintegrating agent and other adjuvant, and Sang Ju Yin flu extract is wherein made by the following weight Chinese medicinal raw materials: Folium Mori 200, Flos Chrysanthemi 80, Semen Armeniacae Amarum 160, Fructus Forsythiae 120, Herba Menthae 64, Radix Platycodonis 160, Rhizoma Phragmitis 160, Radix Glycyrrhizae 64.
Sangju effervescent tablet for treating common cold, wherein each constituent proportioning is by weight: Sang Ju Yin flu extract 1-50 part, disintegrating agent comprises sour agent 10-30 part, alkaline agent 10-30 part, other adjuvant comprises binding agent 0-15 part, lubricant 0-15 part, sweeting agent 0-10 part, aromatic 0-5 part.
Sangju effervescent tablet for treating common cold, wherein the effervescent tablet profile is an annular.
The annular of Sangju effervescent tablet for treating common cold is made up of some bursts; Be provided with the connecting band of easy fracture between each burst.Disintegration rate can be further accelerated in the setting of connecting band between the burst.
An important feature of the present invention is that ring segment is incorporated into the Sangju effervescent tablet for treating common cold preparation field, has invented the Sang Ju Yin annular effervescent tablet of catching a cold.Contain various saccharides, polysaccharide macromolecular material in the Sang Ju Yin flu medical material, so the Sang Ju Yin that makes after drying flu extract has very strong viscosity.After being made into Sangju effervescent tablet for treating common cold, these materials form one deck adhesive film in tablet surface easily when effervescent tablet is met the water disintegrate, influence the disintegration rate of effervescent tablet.After being made into ring segment, increased the contact surface of disintegrating agent and water, made disintegrating agent outer two aspects and water effect of ring in ring, increased the contact surface with water, made effervescent tablet complete disintegrate in the short time.
Because health care products effervescent dosage form and Western medicine effervescent dosage form are very fast because of self Material Characteristics disintegrate, health care products effervescent dosage form and Western medicine effervescent dosage form are made the technical meaning that ring segment further improves disintegration rate do not give prominence to.But to Sangju effervescent tablet for treating common cold, be made into annular, but can improve disintegration rate greatly, significant, the annular Sangju effervescent tablet for treating common cold of disintegrate had both met national standard in two minutes even in one minute, can satisfy patient's demand easy to use again; Need the disintegrate of 4-5 minute ability to compare with common Sangju effervescent tablet for treating common cold, the commercial value of annular Sangju effervescent tablet for treating common cold aspect the disintegrate convenience is higher.
The acid agent can be selected from one or more in tartaric acid, malic acid, fumaric acid, anhydrous citric acid, citric acid or the sodium dihydrogen citrate salt; Alkaline agent can be selected from one or more in potassium carbonate, potassium bicarbonate, sodium carbonate, sodium bicarbonate, calcium carbonate, the calcium bicarbonate; Binding agent can be selected from carboxymethylstach sodium, hyprolose, carmethose, low-substituted hydroxypropyl cellulose (L-HPC), microcrystalline Cellulose (MCC), crospolyvinylpyrrolidone (PVPP), polyvinylpyrrolidone (PVP), Polyethylene Glycol (PEG) 6000, Polyethylene Glycol (PEG) 4000.
Lubricant can be selected from one or more in sodium lauryl sulphate, magnesium stearate, Pulvis Talci, the silicon dioxide.
In the additive of tablet field, materials such as Polyethylene Glycol (PEG) 6000, Polyethylene Glycol (PEG) 4000 have the effect of binding agent, lubricant simultaneously concurrently.It is divided into binding agent or lubricant all belongs to normal.
In the additive of tablet field, have the effect that binding agent, speed collapse agent simultaneously concurrently as carboxymethylstach sodium, hyprolose, carmethose, low-substituted hydroxypropyl cellulose (L-HPC), microcrystalline Cellulose (MCC), crospolyvinylpyrrolidone (PVPP), the polyvinylpyrrolidone (PVP) of binding agent.It is divided into binding agent or speed collapses agent and all belongs to normal.
Sweeting agent can be selected from one or more in cyclamate, steviosin, acesulfame potassium, aspartame, protein sugar, sucrose, the saccharin sodium (calcium) etc.
Aromatic can be selected from one or more among orange essence, flavoring orange essence, Herba Menthae essence or Fructus Citri Limoniae essence, the flavoring banana essence etc.
Effervescent tablet of the present invention was taken after every day, three times consumption was dissolved in water by each 1-3 sheet.
Being conventional substances because sour agent, alkaline agent, binding agent, lubricant, sweeting agent, aromatic, the speed in effervescent tablet field collapse the kind of agent, is not emphasis of the present invention.So the present invention does not do detailed expansion to this partial content.
Sangju effervescent tablet for treating common cold of the present invention can be by following three kinds of methods preparation, and concrete steps are:
Method one: (1) spray-dried airtight preservation of Sang Ju Yin flu extract that obtains is standby; Sour agent, alkaline agent, binding agent pulverize separately are crossed the 80-100 mesh sieve, and airtight preservation is standby; Sweeting agent and aromatic were pulverized the 100-120 mesh sieve, and lubricant was pulverized the 140-200 mesh sieve; In the preparation process control preparation ambient temperature at 25 ℃, humidity below 45%; (2) by required proportioning with Sang Ju Yin catch a cold extract and sour agent mix homogeneously, or add sweeting agent again or/and the aromatic mix homogeneously, powders A 1; (3), get powder B1 with the alkaline agent mix homogeneously; (4) powders A 1 is mixed with powder B1, add lubricant, fully mixing; (5) with the 4th step gained mixed-powder tabletting, obtain required Sangju effervescent tablet for treating common cold.
Method two: (1) spray-dried airtight preservation of Sang Ju Yin flu extract that obtains is standby; Sour agent, alkaline agent, binding agent pulverize separately are crossed the 80-100 mesh sieve, and airtight preservation is standby; Sweeting agent and aromatic were pulverized the 100-120 mesh sieve, and lubricant was pulverized the 140-200 mesh sieve; In the preparation process control preparation ambient temperature at 25 ℃, humidity below 45%; (2) by required proportioning with Sang Ju Yin catch a cold extract and sour agent mix homogeneously, or add sweeting agent again or/and the aromatic mix homogeneously is granulated, granule A2; (3), granulate with the alkaline agent mix homogeneously; Get granule B2; (4) granule A2 is mixed with granule B2, add lubricant, fully mixing; (5) with the 4th step gained hybrid particles tabletting, obtain required Sangju effervescent tablet for treating common cold.
Method three: (1) spray-dried airtight preservation of Sang Ju Yin flu extract that obtains is standby; Sour agent, alkaline agent, binding agent pulverize separately are crossed the 80-100 mesh sieve, and airtight preservation is standby; Sweeting agent and aromatic were pulverized the 100-120 mesh sieve, and lubricant was pulverized the 140-200 mesh sieve; In the preparation process control preparation ambient temperature at 25 ℃, humidity below 45%; (2) by required proportioning with Sang Ju Yin catch a cold extract and sour agent mix homogeneously, or add sweeting agent again or/and the aromatic mix homogeneously, powders A 3; (3), get powder B3 with the alkaline agent mix homogeneously; (4) powders A 3 is mixed with powder B3, add lubricant, fully mixing; (5) the 4th step gained mixed-powder is added non-aqueous solution (as ethanol, isopropyl alcohol etc.) pelletizing press sheet, obtain required Sangju effervescent tablet for treating common cold.
Experimental example:
Sang Ju Yin that the spray drying of learning from else's experience respectively obtains flu extract 80g, the citric acid 50g that pulverized 100 mesh sieves, sodium bicarbonate 55g, low-substituted hydroxypropyl cellulose (L-HPC) 10g, the PEG4000 5g that pulverized 120 mesh sieves make the Sangju effervescent tablet for treating common cold of about 4g/ sheet by above-mentioned three kinds of preparation methoies, control in the preparation process preparation ambient temperature at 25 ℃, humidity below 45%.Prepared Sangju effervescent tablet for treating common cold is with reference to " 2000 editions one appendix XII A of Chinese pharmacopoeia inspection technique disintegration detects, and the result is up to specification.
Check result disintegration of three kinds of preparation method gained Sangju effervescent tablet for treating common cold
Respectively getting 8 averages and investigates disintegration
| Method | Disintegration (min) |
| Method one (not adding the L-HPC solid sheet) method one (adding the L-HPC solid sheet) method one (adding the L-HPC ring segment) method two (not adding the L-HPC solid sheet) method two (adding the L-HPC solid sheet) method two (adding the L-HPC ring segment) method three (not adding the L-HPC solid sheet) method three (adding the L-HPC solid sheet) method three (adding the L-HPC ring segment) | 5.23 5.05 2.79 5.55 5.24 3.64 4.97 4.74 3.93 |
An important feature of the present invention is that the tablet speed commonly used that has added other in the pelletization collapses agent (also having the binding agent effect concurrently) as low-substituted hydroxypropyl cellulose (L-HPC), as can be seen from the table, prepare Sangju effervescent tablet for treating common cold by above-mentioned three kinds of methods, the effervescent tablet that adds L-HPC is shorter than the effervescent tablet disintegration time that does not add L-HPC, and can significantly improve disintegration rate after making annular effervescent tablet.
Other gets above-mentioned raw materials, is pressed into the annular Sangju effervescent tablet for treating common cold of being made up of connecting band between some bursts and the burst.Contrast disintegration with common annular Sangju effervescent tablet for treating common cold:
Respectively getting 8 averages and investigates disintegration
| Method | Disintegration (min) |
| Method one (not adding the common ring segment of L-HPC) method one (not adding L-HPC with the ring segment of burst) method one (adding the common ring segment of L-HPC) method one (adds L-HPC with burst | 3.23 2.47 2.79 2.24 |
| Ring segment) method two (not adding the common ring segment of L-HPC) method two (not adding L-HPC with the ring segment of burst) method two (adding the common ring segment of L-HPC) method two (adding L-HPC with the ring segment of burst) | 3.45 2.35 3.64 1.71 |
In the above-mentioned preparation method, granulating process can adopt methods such as wet granulation, dry granulation, one-step palletizing when big production.
The effervescent tablet of preparation health:
(1) it is standby to get the airtight preservation of vitamin C 10g.Citric acid 150g, sodium bicarbonate 100g, sodium carbonate 10g pulverize separately are crossed 100 mesh sieves, and airtight preservation is standby; Aspartame 8g and essence 1g pulverized 100 mesh sieves, and PEG 6000 21g pulverized 140 mesh sieves; In the preparation process control preparation ambient temperature at 25 ℃, humidity below 45%; With vitamin C and citric acid mix homogeneously, add steviosin and essence mix homogeneously by required proportioning again, granulate, get granule A; With sodium bicarbonate, sodium carbonate mix homogeneously, granulate, get granule B; Granule A is mixed with granule B, add PEG 6000, fully mixing; The gained hybrid particles is divided into identical two parts, and tabletting gets 50 of 50 of solid effervescent tablets of vitamin C and vitamin C annular effervescent tablets.
Adopt method for preparing other than ring type be that solid vitamin C effervescent tablet and vitamin C annular effervescent tablet is about the 3g/ sheet, the outer ring diameter of wherein annular effervescent dosage form is 20 millimeters, interior ring diameter is 8 millimeters.
(2) the airtight preservation of extracting lactic acid calcium 10g is standby.Citric acid 150g, sodium bicarbonate 100g, sodium carbonate 10g pulverize separately are crossed 100 mesh sieves, and airtight preservation is standby; Aspartame 8g and essence 1g pulverized 100 mesh sieves, and PEG 6000 21g pulverized 140 mesh sieves; In the preparation process control preparation ambient temperature at 25 ℃, humidity below 45%; With calcium lactate and citric acid mix homogeneously, add steviosin and essence mix homogeneously by required proportioning again, granulate, get granule A; With sodium bicarbonate, sodium carbonate mix homogeneously, granulate, get granule B; Granule A is mixed with granule B, add PEG 6000, fully mixing; The gained hybrid particles is divided into identical two parts, and tabletting gets 50 of 50 of solid effervescent tablets of calcium lactate and calcium lactate annular effervescent tablets.
Adopt method for preparing other than ring type be that solid calcium lactate effervescent tablet and calcium lactate annular effervescent tablet is about the 3g/ sheet, the outer ring diameter of wherein annular effervescent dosage form is 20 millimeters, interior ring diameter is 8 millimeters.
With reference to " 2000 editions one appendix XII A of Chinese pharmacopoeia inspection technique disintegration is checked, 25 ℃ of a slice effervescent tablet inputs are filled in the 250ml beaker of 200ml water, there are a large amount of bubbles to emit immediately, tablet dissolves, is scattered in the water rapidly, formed even or clear solution in 5 minutes, it is left not have accumulative granule.Check respectively 6 all qualified, the result is up to specification.
Check result disintegration of two kinds of vitamin C effervescent tablets
| Method | Disintegration (min) |
| Solid vitamin C effervescent tablet annular vitamin C effervescent tablet | 0.44±0.4 0.40±0.4 |
Check result disintegration of two kinds of calcium lactate effervescent tablets
| Method | Disintegration (min) |
| Solid calcium lactate effervescent tablet annular calcium lactate effervescent tablet | 0.72±0.4 0.67±0.4 |
As can be known from the results, the vitamin C effervescent tablet of health, calcium lactate effervescent tablet, do not relate to curative effect, every contained vitamin C or calcium lactate are less, and there is not the interference of the multiple stickum such as pectin class, saccharide, polysaccharide of Chinese medicine, so disintegration rate is fast, there is not the slow technical barrier of similar Chinese medicine effervescent tablet disintegration rate.The effervescent tablet of health is prepared into the effect that annular has only novelty attractive in appearance, adopts annular and other than ring type vitamin C or calcium lactate effervescent tablet, it is limited to compare the disintegration rate raising, does not have obvious technological progress.
The dose of Western medicine is less, and is similar with vitamin C, the calcium lactate effervescent tablet of health aspect the disintegration rate raising, and annular is compared the disintegration rate raising with other than ring type Western medicine effervescent tablet limited, do not have obvious technological progress.
The present invention uses the modern pharmaceutical technology, it is carried out the dosage form process modification, thereby obtain a kind of Sangju effervescent tablet for treating common cold, many weak points of original dosage form have been remedied, and make it become a kind of production technology by optimization more to become fully rationally, quality is easy to control, and drug release rate is fast, the bioavailability height carries, the Sang Ju Yin of taking convenience flu new formulation.
Each burst and connecting band can will be stamped to form after the medicated powder filling by the corresponding mould of design, and the realization of this technology can just can be finished by corresponding simple mould design.
The disintegration rate of solid Chinese medicine effervescent reaches several minutes, compare advantage with Chinese medicine granules not outstanding, its practicality is very poor, has limited the application of solid Chinese medicine effervescent, and Here it is does not see one of major reason of Chinese medicine being made oral annular effervescent dosage form report for a long time.When annular Chinese medicine effervescent dosage form was compared the obvious raising of disintegration rate with solid effervescent tablet after, its practicality improved greatly, can satisfy the demand of consumption market.Because health care products effervescent dosage form and Western medicine effervescent dosage form are very fast because of self Material Characteristics disintegrate, health care products effervescent dosage form and Western medicine effervescent dosage form are made the technical meaning that ring segment further improves disintegration rate do not give prominence to.But to the Chinese medicine effervescent tablet, be made into annular, but can improve disintegration rate greatly, significant, the annular Chinese medicine effervescent tablet of disintegrate had both met national standard in two minutes even in one minute, can satisfy patient's demand easy to use again; Need the disintegrate of 4-5 minute ability to compare with solid Chinese medicine effervescent tablet, the commercial value of annular Chinese medicine effervescent tablet aspect the disintegrate convenience is higher.
Specific embodiment:
Embodiment 1
1, the preparation of Sang Ju Yin flu extract: get 64 parts on 200 parts on Folium Mori, 80 parts of Flos Chrysanthemis, 160 parts of Semen Armeniacae Amarums, 120 parts of Fructus Forsythiaes, 64 parts of Herba Menthaes, 160 parts of Radix Platycodoniss, 160 parts of Rhizoma Phragmitiss, Radix Glycyrrhizae totally eight flavors.Add the water distillation behind the Semen Armeniacae Amarum pressure degrease oil and produce 160 parts of bitter almond waters; Herba Menthae is extracted volatile oil; Six-elements such as medicinal residues and all the other Folium Mori decoct with water three times, collecting decoction filters, and filtrate is concentrated into 840 parts, merge after drying with 160 parts of bitter almond waters again and obtain dried cream powder, Herba Menthae Haplocalycis volatile oil adds a little dextrin parcel back and promptly gets Sang Ju Yin flu extract with the dried cream powder mixing.To adopt be drying under reduced pressure or spray drying to the drying of extract in the technology.The drying under reduced pressure temperature is controlled at 50-80 ℃, and the best is 60 ℃.Obtain 63 parts of Sang Ju Yin flu extracts altogether, yield 6.3%.
2, preparation Sang Ju Yin flu effervescent solid sheet (100)
The prescription proportioning:
Sang Ju Yin flu extract 134g citric acid 116g
Steviosin 3g essence 1g
Sodium bicarbonate 90g sodium carbonate 10g
Low-substituted hydroxypropyl cellulose 25g PEG 6000 21g
3, preparation method
The spray-dried airtight preservation of Sang Ju Yin flu extract that obtains is standby; Citric acid, sodium bicarbonate, sodium carbonate, low-substituted hydroxypropyl cellulose pulverize separately are crossed 100 mesh sieves, and airtight preservation is standby; Steviosin and essence were pulverized 100 mesh sieves, and PEG 6000 pulverized 140 mesh sieves; In the preparation process control preparation ambient temperature at 25 ℃, humidity below 45%; With Sang Ju Yin catch a cold extract and citric acid mix homogeneously, add steviosin and essence mix homogeneously by required proportioning again, powders A 1; With sodium bicarbonate, sodium carbonate mix homogeneously, get powder B1; Powders A 1 is mixed with powder B1, add low-substituted hydroxypropyl cellulose, PEG 6000, fully mixing; Be pressed into solid sheet, get 100 of Sangju effervescent tablet for treating common cold.
The average sheet of gained Sangju effervescent tablet for treating common cold heavily is 4.00 ± 0.04g, any surface finish, exquisiteness.With reference to " 2000 editions one appendix XII A of Chinese pharmacopoeia inspection technique disintegration is checked this product, 25 ℃ of a slice effervescent tablet inputs are filled in the 250ml beaker of 200ml water, there are a large amount of bubbles to emit immediately, tablet dissolves, is scattered in the water rapidly, formed light yellow transparent solution in 6 minutes, it is left not have accumulative granule.
Embodiment 2
1, the preparation of Sang Ju Yin flu extract: with embodiment 1.
2, the Sang Ju Yin annular effervescent tablet (100) of catching a cold
The prescription proportioning:
Sang Ju Yin flu extract 77g tartaric acid 138g
Cyclamate 5g essence 2g
Sodium bicarbonate 126g PEG 4000 5g
Polyvinylpolypyrrolidone 24g PVP 23g
3, preparation method
The spray-dried airtight preservation of Sang Ju Yin flu extract that obtains is standby; Tartaric acid, sodium bicarbonate, microcrystalline Cellulose pulverize separately are crossed 100 mesh sieves, and airtight preservation is standby; Cyclamate and essence were pulverized 100 mesh sieves, and PEG 4000 pulverized 140 mesh sieves; In the preparation process control preparation ambient temperature at 25 ℃, humidity below 45%; With Sang Ju Yin catch a cold extract and tartaric acid mix homogeneously, add cyclamate and essence mix homogeneously by required proportioning again, powders A 2; With the sodium bicarbonate mix homogeneously, get powder B2; Powders A 2 is mixed with powder B2, add microcrystalline Cellulose, PEG 4000, fully mixing; The gained mixed-powder is granulated with the alcoholic solution of 3% PVP, tabletting, catch a cold 100 of annular effervescent tablets of Sang Ju Yin.
The gained Sang Ju Yin average sheet of annular effervescent tablet of catching a cold heavily is 4.02 ± 0.03g, any surface finish, exquisiteness.With reference to " 2000 editions one appendix XII A of Chinese pharmacopoeia inspection technique disintegration is checked this product, 25 ℃ of a slice effervescent tablet inputs are filled in the 250ml beaker of 200ml water, there are a large amount of bubbles to emit immediately, tablet dissolves, is scattered in the water rapidly, formed light yellow transparent solution in 5 minutes, it is left not have accumulative granule.Check 6 all qualified, the result is up to specification.
Embodiment 3
1, the preparation of Sang Ju Yin flu extract: with embodiment 1.
2, the preparation Sang Ju Yin annular effervescent tablet (100) of catching a cold
The prescription proportioning:
Sang Ju Yin flu extract 44g citric acid 125g
Aspartame 7g acesulfame potassium 5g essence 2g
Sodium bicarbonate 78g potassium carbonate 90g
Sodium carboxymethyl cellulose 37g magnesium stearate 12g
3, preparation method
The spray-dried airtight preservation of Sang Ju Yin flu extract that obtains is standby; Malic acid, citric acid, sodium bicarbonate, potassium carbonate, crospolyvinylpyrrolidone pulverize separately are crossed 100 mesh sieves, and airtight preservation is standby; Acesulfame potassium and essence were pulverized 100 mesh sieves, and magnesium stearate was pulverized 140 mesh sieves; In the preparation process control preparation ambient temperature at 25 ℃, humidity below 45%; With Sang Ju Yin catch a cold extract and malic acid mix homogeneously, add aspartame, acesulfame potassium and essence mix homogeneously by required proportioning again, granulate, granule A3; With sodium bicarbonate, potassium carbonate mix homogeneously, granulate, get granule B3; Granule A3 is mixed with granule B3, add crospolyvinylpyrrolidone, magnesium stearate, fully mixing; Tabletting, catch a cold 100 of annular effervescent tablets of Sang Ju Yin.
The average sheet of gained Sangju effervescent tablet for treating common cold heavily is 3.99 ± 0.04g, any surface finish, exquisiteness.With reference to " 2000 editions one appendix XII A of Chinese pharmacopoeia inspection technique disintegration is checked this product, 25 ℃ of a slice effervescent tablet inputs are filled in the 250ml beaker of 200ml water, there are a large amount of bubbles to emit immediately, tablet dissolves, is scattered in the water rapidly, formed light yellow transparent solution in 5 minutes, it is left not have accumulative granule.Check 6 all qualified, the result is up to specification.
Embodiment 4
Sangju effervescent tablet for treating common cold, the composition of this effervescent tablet comprise Sang Ju Yin flu extract, disintegrating agent and other adjuvant.
(1) Sang Ju Yin flu extract is wherein made by the following weight Chinese medicinal raw materials: Folium Mori 240, Flos Chrysanthemi 120, Semen Armeniacae Amarum 120, Fructus Forsythiae 80, Herba Menthae 100, Radix Platycodonis 120, Rhizoma Phragmitis 120, Radix Glycyrrhizae 40.
It is stand-by to obtain Sang Ju Yin flu extract by the method for embodiment 1, and wherein Sang Ju Yin flu extract extraction ratio is 6.8%, and promptly 6.8g Sang Ju Yin flu extract is equivalent to the 100g raw material of Chinese medicine.
(2) Sangju effervescent tablet for treating common cold, each constituent proportioning is by weight:
Get 50 parts of Sang Ju Yin flu extracts, disintegrating agent comprises 30 parts of sour agent, 30 parts of alkaline agents, 15 parts of lubricants, 10 parts of sweeting agents.
Sweeting agent is selected from 4 parts of steviosin, 2 parts of acesulfame potassiums, 4 parts of aspartames; The acid agent is selected from 14 parts of malic acids, 16 parts of anhydrous citric acids; Alkaline agent is selected from 15 parts of sodium bicarbonate, 15 parts of calcium bicarbonate; Lubricant is selected from 5 parts of sodium lauryl sulphates, 10 parts of magnesium stearate.All the other repeat embodiment 1,2,3 respectively.
Embodiment 5
(1) Sang Ju Yin flu extract is wherein made by the following weight Chinese medicinal raw materials: Folium Mori 160, Flos Chrysanthemi 40, Semen Armeniacae Amarum 200, Fructus Forsythiae 160, Herba Menthae 40, Radix Platycodonis 200, Rhizoma Phragmitis 200, Radix Glycyrrhizae 100.It is stand-by to obtain Sang Ju Yin flu extract by the method for embodiment 1, and wherein Sang Ju Yin flu extract extraction ratio is 7.5%, and promptly 7.5g Sang Ju Yin flu extract is equivalent to the 100g raw material of Chinese medicine.
(2) Sangju effervescent tablet for treating common cold, each constituent proportioning is by weight:
Get 1 part of above-mentioned stand-by Sang Ju Yin flu extract, disintegrating agent comprises 10 parts of sour agent, 10 parts of alkaline agents, 15 parts of binding agents, 5 parts of aromatic.
Aromatic wherein is selected from 2 parts of orange essences, 3 parts of flavoring orange essences.The acid agent is selected from 6 parts of citric acids, 4 parts in tartaric acid; Alkaline agent is selected from 2 parts of potassium carbonate, 1 part of potassium bicarbonate, 4 parts of sodium carbonate, 3 parts of sodium bicarbonate; Binding agent is selected from 10 parts of microcrystalline Cellulose, 5 parts of polyvinylpyrrolidones (PVP).All the other repeat embodiment 1,2,3 respectively.
Embodiment 6
Sangju effervescent tablet for treating common cold, each constituent proportioning is by weight: get 20 parts of Sang Ju Yin flu extracts, disintegrating agent comprises 20 parts of sour agent, 20 parts of alkaline agents, 3 parts of binding agents, 4 parts of lubricants, 6 parts of sweeting agents, 3 parts of aromatic.
Sweeting agent is selected from 2 parts of steviosin, 2 parts of sucrose, 2 parts of Calcium o-benzolsulfimides; Aromatic is selected from respectively 1 part of Herba Menthae essence, Fructus Citri Limoniae essence, flavoring banana essence; The acid agent is selected from 10 parts in tartaric acid, 10 parts of malic acids; Alkaline agent is selected from 15 parts of sodium bicarbonate, 5 parts of sodium carbonate; Binding agent is selected from 1 part of microcrystalline Cellulose (MCC), 2 parts of crospolyvinylpyrrolidone (PVPP); Lubricant is selected from 3 parts of sodium lauryl sulphates, silica 1 part.All the other are with embodiment 3.
Embodiment 7
Get the Sangju effervescent tablet for treating common cold of embodiment 1,2,3,4,5,6, it is prepared into outer ring diameter respectively is 30 millimeters, and interior ring diameter is 3 millimeters a ring segment.
Embodiment 8
Get the Sangju effervescent tablet for treating common cold of embodiment 1,2,3,4,5,6, it is prepared into outer ring diameter respectively is 20 millimeters, and interior ring diameter is 8 millimeters a ring segment.
Embodiment 9
Get the Sangju effervescent tablet for treating common cold of embodiment 1,2,3,4,5,6, it is prepared into outer ring diameter respectively is 25 millimeters, and interior ring diameter is 5 millimeters a ring segment.
Embodiment 10
Get the Sangju effervescent tablet for treating common cold of embodiment 1,2,3,4,5,6, it is prepared into annular respectively forms, be provided with the ring segment of the connecting band of easy fracture between each burst by some bursts.
Claims (5)
1, a kind of Sangju effervescent tablet for treating common cold, the composition that it is characterized in that this effervescent tablet comprises Sang Ju Yin flu extract, disintegrating agent and other adjuvant, and Sang Ju Yin flu extract is wherein made by the following weight Chinese medicinal raw materials: Folium Mori 160-240, Flos Chrysanthemi 40-120, Semen Armeniacae Amarum 120-200, Fructus Forsythiae 80-160, Herba Menthae 40-100, Radix Platycodonis 120-200, Rhizoma Phragmitis 120-200, Radix Glycyrrhizae 40-100.。
2, Sangju effervescent tablet for treating common cold as claimed in claim 1 is characterized in that Sang Ju Yin flu extract made by the following weight Chinese medicinal raw materials: Folium Mori 200, Flos Chrysanthemi 80, Semen Armeniacae Amarum 160, Fructus Forsythiae 120, Herba Menthae 64, Radix Platycodonis 160, Rhizoma Phragmitis 160, Radix Glycyrrhizae 64.
3, Sangju effervescent tablet for treating common cold as claimed in claim 1, it is characterized in that each constituent proportioning is by weight: Sang Ju Yin flu extract 1-50 part, disintegrating agent comprise sour agent 1510-30 part and, alkaline agent 10-30 part, other adjuvant comprises binding agent 0-15 part, lubricant 0-15 part, sweeting agent 0-10 part, aromatic 0-5 part.
4,, it is characterized in that prepared effervescent tablet profile is annular as claim 1 or 2 or 3 described Sangju effervescent tablet for treating common cold.
5, Sangju effervescent tablet for treating common cold as claimed in claim 4 is characterized in that the annular of Sangju effervescent tablet for treating common cold is made up of some bursts; Be provided with the connecting band of easy fracture between each burst.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100195246A CN100546571C (en) | 2005-09-30 | 2005-09-30 | Sangju effervescent tablet for treating common cold |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100195246A CN100546571C (en) | 2005-09-30 | 2005-09-30 | Sangju effervescent tablet for treating common cold |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1742957A true CN1742957A (en) | 2006-03-08 |
| CN100546571C CN100546571C (en) | 2009-10-07 |
Family
ID=36138582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100195246A Expired - Fee Related CN100546571C (en) | 2005-09-30 | 2005-09-30 | Sangju effervescent tablet for treating common cold |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100546571C (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101972027A (en) * | 2010-09-21 | 2011-02-16 | 广州市香雪制药股份有限公司 | Natural plant beverage and preparation method thereof |
| CN102210819A (en) * | 2011-05-26 | 2011-10-12 | 平阴县孔村卫生院 | Medicament for treating anemopyretic cold and preparation method thereof |
| CN102362989A (en) * | 2011-10-03 | 2012-02-29 | 周春根 | Traditional Chinese medicine for treating cough due to wind-heat evil |
| CN103652102A (en) * | 2012-09-03 | 2014-03-26 | 宁国红楼梦旅游产品开发有限公司 | Pathogenic fire-discharging rhizoma phragmitis tea and preparation method thereof |
| CN104225330A (en) * | 2014-09-29 | 2014-12-24 | 洛阳御平国生物科技有限公司 | Traditional Chinese medicine formula for influenza |
| CN104383035A (en) * | 2014-11-04 | 2015-03-04 | 禤燕华 | Traditional Chinese medicine composition for treating wind-warm cough |
| CN104705763A (en) * | 2015-03-07 | 2015-06-17 | 湖北卫尔康现代中药有限公司 | Sangju effervescent tablet |
| CN105687331A (en) * | 2015-01-06 | 2016-06-22 | 徐应乐 | Prescription for treating wind-heat type common cold |
-
2005
- 2005-09-30 CN CNB2005100195246A patent/CN100546571C/en not_active Expired - Fee Related
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101972027A (en) * | 2010-09-21 | 2011-02-16 | 广州市香雪制药股份有限公司 | Natural plant beverage and preparation method thereof |
| CN102210819A (en) * | 2011-05-26 | 2011-10-12 | 平阴县孔村卫生院 | Medicament for treating anemopyretic cold and preparation method thereof |
| CN102210819B (en) * | 2011-05-26 | 2013-01-02 | 平阴县孔村卫生院 | Medicament for treating anemopyretic cold and preparation method thereof |
| CN102362989A (en) * | 2011-10-03 | 2012-02-29 | 周春根 | Traditional Chinese medicine for treating cough due to wind-heat evil |
| CN103652102A (en) * | 2012-09-03 | 2014-03-26 | 宁国红楼梦旅游产品开发有限公司 | Pathogenic fire-discharging rhizoma phragmitis tea and preparation method thereof |
| CN104225330A (en) * | 2014-09-29 | 2014-12-24 | 洛阳御平国生物科技有限公司 | Traditional Chinese medicine formula for influenza |
| CN104383035A (en) * | 2014-11-04 | 2015-03-04 | 禤燕华 | Traditional Chinese medicine composition for treating wind-warm cough |
| CN105687331A (en) * | 2015-01-06 | 2016-06-22 | 徐应乐 | Prescription for treating wind-heat type common cold |
| CN104705763A (en) * | 2015-03-07 | 2015-06-17 | 湖北卫尔康现代中药有限公司 | Sangju effervescent tablet |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100546571C (en) | 2009-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1174745C (en) | Use of coating as taste masking agent for oral preparation | |
| CN1225017A (en) | Quickly disintegrable compression-molded materials and process for producing the same | |
| CN1494419A (en) | Preparations quickly disintegrating in oral cavity | |
| CN1123142A (en) | Fluoxetine pharmaceutical preparations | |
| TW201720428A (en) | Composite particles including cellulose, inorganic compound, and hydroxypropyl cellulose | |
| CN1215861C (en) | Xiasangju effervescent tablet and its preparation process | |
| CN102772444A (en) | Method for processing traditional Chinese medicinal ultramicro wall-broken oral tablet slices | |
| CN102772440A (en) | Processing method of ultra-micro wall-breaking oral-tablet decoction pieces by traditional Chinese medicines | |
| CN1586475A (en) | Vitamin C oral disintegration tablet and its preparing method | |
| CN101007071A (en) | Traditional Chinese medicine for treating acute and chronic gastroenteritis and bacterial dysentery and its processing technology | |
| CN1742957A (en) | Sangju effervescent tablet for treating common cold | |
| CN1762474A (en) | Effervescence tablet for cold | |
| JP4565219B2 (en) | Polyphenol-containing granule or polyphenol-containing chewable tablet and method for producing the same | |
| CN1254246C (en) | Oral disintegration tablet of silaenafil and its pharmaceutically receptible salt and its preparing method | |
| CN1698663A (en) | Ring form effervescence dosage and preparation method thereof | |
| CN1303989C (en) | Zinc gluconate oral disintegrating tablet and its preparation process | |
| CN1682697A (en) | Effervescent lozenge and its preparing process | |
| CN1742956A (en) | Lonicera and Forsythia effervescent tablet for relieving internal heat or fever of humanbody | |
| CN2745572Y (en) | Ring shaped Chinese medicine effervescent form | |
| CN1698664A (en) | Isatic root effervescence tablet and preparation method thereof | |
| CN1698665A (en) | Defervesce effervescence tablet for treating cold and preparation method thereof | |
| CN1698666A (en) | Shuanghuanglian effervescence tablet and preparation thereof | |
| CN1762475A (en) | Effervescence tablet for wind-cold type cold | |
| CN1762482A (en) | Antivirus effervescence tablet | |
| CN1742776A (en) | Flavargine effervescent tablet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091007 Termination date: 20100930 |